170 related articles for article (PubMed ID: 6129159)
1. The biology of schizophrenia.
Crow TJ
Experientia; 1982 Nov; 38(11):1275-82. PubMed ID: 6129159
[No Abstract] [Full Text] [Related]
2. The clinical effects of the isomers of flupenthixol--the consequences of dopamine receptor blockade in acute schizophrenia [proceedings].
Crow TJ; Frith C; Johnstone EC
Br J Clin Pharmacol; 1977 Oct; 4(5):648P. PubMed ID: 911634
[No Abstract] [Full Text] [Related]
3. A report on the use of flupenthixol in the maintenance treatment of psychotic patients at Ibadan, Nigeria.
Jegede RO; Ibazebo H
Afr J Psychiatry; 1981; 7(1-2):21-4. PubMed ID: 6122369
[No Abstract] [Full Text] [Related]
4. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
Coufal J; Novotný M
Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
[No Abstract] [Full Text] [Related]
5. [Schizophrenia and dopamine (author's transl)].
Toru M
Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
[No Abstract] [Full Text] [Related]
6. Note on an abnormality of the operator for the structural gene of the dopamine D1 receptor as a possible partial cause of schizophrenia.
Wassermann GD
J Theor Biol; 1986 Jun; 120(3):277-83. PubMed ID: 2878120
[No Abstract] [Full Text] [Related]
7. Stereochemical specificity in the antipsychotic effects of flupenthixol in man [proceedings].
Crow TJ; Johnstone EC
Br J Pharmacol; 1977 Mar; 59(3):466P. PubMed ID: 14758
[No Abstract] [Full Text] [Related]
8. Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process.
Crow TJ; Johnstone EC; Longden AJ; Owen F
Life Sci; 1978 Aug; 23(6):563-7. PubMed ID: 29195
[No Abstract] [Full Text] [Related]
9. Biochemical aspects of schizophrenia.
Lewis ME
Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
[No Abstract] [Full Text] [Related]
10. Dopamine and schizophrenia.
Crow TJ; Johnstone EC; Longden A; Owen F
Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
[No Abstract] [Full Text] [Related]
11. Mechanisms of antipsychotic effect in treatment of acute schizophrenia.
Meltzer HY
Lancet; 1978 May; 1(8074):1151-2. PubMed ID: 77438
[No Abstract] [Full Text] [Related]
12. Skin conductance responsivity during acute episodes of schizophrenia as a predictor of symptomatic improvement.
Frith CD; Stevens M; Johnstone EC; Crow TJ
Psychol Med; 1979 Feb; 9(1):101-6. PubMed ID: 424477
[TBL] [Abstract][Full Text] [Related]
13. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
Ehmann TS; Delva NJ; Beninger RJ
J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
[TBL] [Abstract][Full Text] [Related]
14. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
Kong DS; Yeo SH
Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
[No Abstract] [Full Text] [Related]
15. Dopamine receptors and schizophrenia.
Reynolds GP
Biochem Soc Trans; 1996 Feb; 24(1):202-5. PubMed ID: 8674664
[No Abstract] [Full Text] [Related]
16. Flupenthixol decanoate--in treatment of out-patients.
Gottfries CG; Green L
Acta Psychiatr Scand Suppl; 1974; 255():15-24. PubMed ID: 4533707
[No Abstract] [Full Text] [Related]
17. [Effect of flupenthixol on the clinical state and EEG recordings in schizoprenics].
Ekiert H; Gogol Z; Welbel L
Psychiatr Pol; 1977; 11(1):7-14. PubMed ID: 847055
[No Abstract] [Full Text] [Related]
18. Pathophysiology of schizophrenia: dopamine hypothesis.
Neylan TC
J Neuropsychiatry Clin Neurosci; 1996; 8(2):222. PubMed ID: 9081562
[No Abstract] [Full Text] [Related]
19. Neurotransmitters and CNS disease. Schizophrenia.
Snyder SH
Lancet; 1982 Oct; 2(8305):970-4. PubMed ID: 6127468
[No Abstract] [Full Text] [Related]
20. [Schizophrenia as a dopamine excess syndrome].
Toru M
Nihon Rinsho; 1983 May; 41(5):1021-7. PubMed ID: 6138444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
